http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
손진욱(J W Sohn),하우송(W S Ha),전시영(S Y Jeon),정성훈(S H Chung),김종화(C H Kim) 한국의학교육학회 1990 Korean journal of medical education Vol.2 No.1
A common objective in undergraduate medical examination is to achieve the basic qualities of a primary health care physician. The educational domains for above object are knowledge, technical skill, and attitude. But, there are few evaluating tools for students skills and attitude rather than for knowledge. We did 3 experimental trials to undergraduate students for developing the objective and valid tools for evaluation of skills and attitude in medical education. Now, we present the methods and results of our experiences during last 3 years.
김종화 ( C H Kim ),이동민 ( D H Lee ),김용성 ( Y S Kim ),최보금 ( B G Choi ),박주형 ( J H Park ),김신재 ( S J Kim ),이치국 ( C K Lee ),전현순 ( H S Jeon ),류완희 ( W H Yoo ),곽재용 ( J Y Kwak ),백홍선 ( H S Baek ) 전북대학교 의과학연구소 2001 全北醫大論文集 Vol.25 No.1
ASU 치료는 증상을 갖고 있는 슬관절의 골관절염 환자의 통증 개선과 관절 기능을 호전시키고, 약물투여 중지 후에 지속효과를 갖는 증상개선 약제로서 안전하게 사용할 수 있을 것으로 보인다. 소염진통제인 naproxen과의 병용치료와의 비교에서는 병용치료 군에서 효과의 발현시기와 전반적인 평가에서는 우월하였으나, 부작용이 보다 많이 발생하였다. 따라서 ASU를 골관절염의 약물치료의 한 방법으로 사용될 수 있을 것으로 보이며, 단순진통제 및 소염진통제 등의 약물 등과 같이 단일요법으로서의 사용과 다른 약물과의 병용치료의 효과 및 안정성에 대해서는 보다 많은 연구가 필요할 것으로 보인다. Objective: To compare the efficacy and safety between avocado/soybean unsaponifiables (ASU) alone and ASU-naproxen combination in the treatment of symptomatic osteoarthritis (OA) of the knee and to determine persistent efficacy after stopping medication and gastrointestinal tolerability. Methods: One hundred twenty-five patients with symptomatic OA of the knee were included in 20-week trial with 12-week treatment period and 8-weeks post-treatment follow-up. Efficacy was evaluated by Lequesne`s index (LI), pain score (VAS; visual analong scale. 10cm) at 4-week interval during the study and physician`s and patient`s global assessment at 20th week. Gastrointestinal side effects were evaluated by questionnaire for gastrointestinal symptoms and number of the ingested antacids during the study. Results: Sixty-three patients were received ASU alone, while sixty-two patients were received ASU and naproxen. Mean±SD scores of pain VAS score were reased from baseline at 8th and 12th weeks after medication in the former groups and 4th, 8th and 12th weeks in the latter groups. Mean±SD scores of LI were decreased from baseline at 12th week after medication in the former groups and 4th, 8th, 12th week in the latter groups. Both scores of LI and pain VAS were maintained at 8th week after stopping medication. The scores of LI and pain VAS scale were significantly decreased in combination group than ASU alone group at 4th and 8th weeks, but tended to lower in combination group at 12th week and post-treatment period. The improvement of physician`s global assessment was seen in 65.4% of combination and 53.2% of ASU alone group. The patient`s global assessment was similar to it. Twenty-six patients (20.8%) could not complete the 20-week study and the causes are different in two groups: side effects are more common cause in combination group and low efficacy and non-compliance were more common in ASU alone group. Gastrointestinal side effects are the most common adverse effects of the both groups, and the frequencies are more common in patients received naproxen as a combination therapy. Conclusion: ASU showed immediate and persistent efficacy in the treatment of patients with symptomatic OA of the knee. The combination of ASU and naproxen was more effective than ASU alone during the treatment period, but similar at post-treatment period. Gastrointestinal side effects were more frequent in combination group than ASU alone.